Novo Nordisk A/S (NVO) Social Stream
Novo Nordisk A S (NVO) Price Targets From Analysts
Use the tables below to see what analysts covering Novo Nordisk A S think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 20 months, NVO's average price target has gone up $50.62.
NVO reports an average of 11.38% for its upside potential over the past 97 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
NVO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
NVO's average broker recommendation rating worsened by 0.44 over the prior 16 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- NVO has a greater number of analysts covering the stock than 0.22% of stocks in the mega market cap category.
- In terms of how Novo Nordisk A S fares relative to stocks in the mega market cap category, note that its variance in analysts' estimates is lower than 98.79% of that group.
- In terms of how Novo Nordisk A S fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 4.44% of that group.
- NVO has a greater average analyst price target than 87.68% of Pharmaceutical Products stocks.
Make investment decisions regarding NVO using the data that counts. Try POWR Ratings for free.